title: Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks?
authors.affiliation: College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA. tself@utmem.edu
authors.forename: Timothy
authors.initials: T
authors.lastname: Self
authors.forename: Judith E
authors.initials: JE
authors.lastname: Soberman
authors.forename: Jamie M
authors.initials: JM
authors.lastname: Bubla
authors.forename: Carol C
authors.initials: CC
authors.lastname: Chafin
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001249:Asthma / Q000150:complications*; D001986:Bronchial Spasm / Q000139:chemically induced* / Q000188:drug therapy; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D012720:Severity of Illness Index
chemical_list: D000319:Adrenergic beta-Antagonists